EVOXAC Efficacy and Clinical Studies.
EVOXAC is a cholinergic agonist which binds to muscarinic receptors and significantly improves salivary flow for patients suffering from dry mouth associated with Sjögren's syndrome. Nine clinical trials have shown EVOXAC to be both safe and effective. Evoxac. April, 2011. (Also see: Sjogrens)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
EVOXAC Efficacy and Clinical Studies
1 reply to this topic
Posted 04 May 2011 - 07:07 AM
I've been on this drug before. It does increase saliva flow; however, the down side is they are expensive pills and you have to take 2 or 3 per day. I found that if I took more than 1 per day, I would get sick to my stomach. They also make you sweat profusely after taking the pill for about the first couple of hours after taking. But again, they did help increase saliva production.